• Connect with us
  • Subscription Link
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn

    Stephanie Trunk To Present Online CLE Course On Reimbursement Framework For Biosimilars

    On February 24, 2017 partner Stephanie Trunk will present on online CLE course via Lawline on the topic of “Reimbursement Framework for Biosimilars.” In this program, Stephanie will examine the reimbursement framework that surrounds biosimilars. A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an FDA-approved biological product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product.  Attendees will learn about how biosimilars are currently treated and reimbursed under various programs, including:
    • Medicare Part B
    • Part D
    • Medicaid
    • Qualified Health Plans sold on Exchanges
    • Various commercial plans
    The program will also discuss potential changes to biosimilar reimbursement under the new Administration. To learn more about the program and to sign up, click here.